{"id":393966,"date":"2020-12-07T04:14:36","date_gmt":"2020-12-07T09:14:36","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=393966"},"modified":"2020-12-07T04:14:36","modified_gmt":"2020-12-07T09:14:36","slug":"oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/","title":{"rendered":"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n STOCKHOLM<\/span>, Dec. 7, 2020<\/span> \/PRNewswire\/ — Oncopeptides AB (publ) <\/b>(Nasdaq Stockholm: ONCO), <\/b>a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company will host a webcast on Wednesday, December 9<\/span>th<\/sup>, 2020, at 14:00 (CET) to provide an update regarding the data presented December 4-8<\/span> at the American Society Hematology (ASH) Annual Meeting 2020.<\/p>\n

At ASH Oncopeptides has presented twelve abstracts, including one oral presentation. Key clinical abstracts focused on new data from the ongoing phase 1\/2 ANCHOR combination study and new data from the pivotal phase 2 HORIZON study. The preclinical abstracts further explored the mechanism of action of the proprietary peptide-drug conjugate platform in multidrug resistant models of multiple myeloma.<\/p>\n

The webcast will be hosted by CEO Marty J Duvall, CSO Jakob Lindberg and CMO Klaas Bakker.<\/p>\n

\n The webcast can be followed via the link:<\/b>
\n
\n https:\/\/tv.streamfabriken.com\/oncopeptides-post-ash-2020<\/a>\n <\/p>\n

\n Participants who would like to ask questions can use the telephone numbers below:<\/b>
\n
SE: +46 8\u00a0505\u00a0583 58
UK: +44 3333 009 266
US: +1\u00a0833\u00a0526 83 82<\/p>\n

\n The presentation can be found at:<\/b>
\n
\n www.oncopeptides.com\/post-ash-2020-webcast-presentation\/<\/a>
\n
\u00a0<\/p>\n

\n For more information, please contact:<\/b>\n <\/p>\n

Rein Piir, Head of Investor Relations, Oncopeptides
E-mail: rein.piir@oncopeptides.com<\/a>
Cell phone: +46 70 853 72 92<\/p>\n

The information was submitted for publication on December 7, 2020<\/span> at 10:00 (CET).<\/p>\n

\n About melflufen <\/b>\n <\/p>\n

Melflufen (INN melphalan flufenamide)\u00a0is a first in class peptide-drug conjugate (PDC) that targets aminopeptidases and rapidly releases alkylating agents into tumor cells. Melflufen is rapidly taken up by myeloma cells due to its high lipophilicity and is immediately hydrolyzed by peptidases to release an entrapped hydrophilic alkylator payload. Aminopeptidases are overexpressed in tumor cells and are even more pronounced in advanced cancers and tumors with a high mutational burden. In vitro, melflufen is 50-fold more potent in myeloma cells than the alkylator payload itself due to the increased intracellular alkylator concentration. Melflufen displays cytotoxic activity against myeloma cell lines resistant to other treatments, including alkylators, and has also demonstrated inhibition of DNA repair induction and angiogenesis in preclinical studies.\u00a0In the pivotal phase 2 HORIZON study melflufen plus dexamethasone demonstrated encouraging efficacy and a clinically manageable safety profile in heavily pretreated patients with relapsed refractory multiple myeloma, with primarily hematologic Adverse Events (AE) and a low incidence of non-hematologic AEs. \u00a0<\/p>\n

\n About Oncopeptides<\/b>\n <\/p>\n

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The lead product candidate melflufen, is a first in class peptide-drug conjugate that targets aminopeptidases and rapidly releases alkylating agents into tumor cells. Melflufen is in development as a new treatment for the hematological malignancy multiple myeloma and is being tested in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study.\u00a0Based on the results from the HORIZON study a New Drug Application has been submitted to the U.S. Food and Drug Administration, FDA, for accelerated approval of melflufen in combination with dexamethasone for treatment of adult patients with triple-class refractory multiple myeloma. The FDA,\u00a0has\u00a0granted the\u00a0New Drug Application a priority review, with a PDUFA date of February 28<\/span>, 2021.Oncopeptides’ global Headquarters is in Stockholm, Sweden<\/span> and the U.S. Headquarters is situated in Boston, Mass.<\/span> The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO. More information is available on\u00a0www.oncopeptides.com<\/a>.<\/p>\n

This information was brought to you by Cision http:\/\/news.cision.com<\/a><\/p>\n

\n https:\/\/news.cision.com\/oncopeptides-ab\/r\/oncopeptides-will-host-a-webcast-on-wednesday–december-9-th–at-14-00–cet–to-provide-an-update-re,c3249890<\/a>\n <\/p>\n

The following files are available for download:<\/p>\n

\n\n\n
\n

\n
\n https:\/\/mb.cision.com\/Main\/15404\/3249890\/1344827.pdf<\/a>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Press release – Oncopeptides will host a post ASH webcast<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting-301187113.html<\/a><\/p>\n

SOURCE Oncopeptides AB<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire STOCKHOLM, Dec. 7, 2020 \/PRNewswire\/ — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company will host a webcast on Wednesday, December 9th, 2020, at 14:00 (CET) to provide an update regarding the data presented December 4-8 at the American Society Hematology (ASH) Annual Meeting 2020. At ASH Oncopeptides has presented twelve abstracts, including one oral presentation. Key clinical abstracts focused on new data from the ongoing phase 1\/2 ANCHOR combination study and new data from the pivotal phase 2 HORIZON study. The preclinical abstracts further explored the mechanism of action of the proprietary peptide-drug conjugate platform in multidrug resistant models of … <\/p>\n

Continue reading “Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-393966","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire STOCKHOLM, Dec. 7, 2020 \/PRNewswire\/ — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company will host a webcast on Wednesday, December 9th, 2020, at 14:00 (CET) to provide an update regarding the data presented December 4-8 at the American Society Hematology (ASH) Annual Meeting 2020. At ASH Oncopeptides has presented twelve abstracts, including one oral presentation. Key clinical abstracts focused on new data from the ongoing phase 1\/2 ANCHOR combination study and new data from the pivotal phase 2 HORIZON study. The preclinical abstracts further explored the mechanism of action of the proprietary peptide-drug conjugate platform in multidrug resistant models of … Continue reading "Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-07T09:14:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO14892&sd=2020-12-07\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting\",\"datePublished\":\"2020-12-07T09:14:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/\"},\"wordCount\":622,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO14892&sd=2020-12-07\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/\",\"name\":\"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO14892&sd=2020-12-07\",\"datePublished\":\"2020-12-07T09:14:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO14892&sd=2020-12-07\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO14892&sd=2020-12-07\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting - Market Newsdesk","og_description":"PR Newswire STOCKHOLM, Dec. 7, 2020 \/PRNewswire\/ — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the company will host a webcast on Wednesday, December 9th, 2020, at 14:00 (CET) to provide an update regarding the data presented December 4-8 at the American Society Hematology (ASH) Annual Meeting 2020. At ASH Oncopeptides has presented twelve abstracts, including one oral presentation. Key clinical abstracts focused on new data from the ongoing phase 1\/2 ANCHOR combination study and new data from the pivotal phase 2 HORIZON study. The preclinical abstracts further explored the mechanism of action of the proprietary peptide-drug conjugate platform in multidrug resistant models of … Continue reading \"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-07T09:14:36+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO14892&sd=2020-12-07","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting","datePublished":"2020-12-07T09:14:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/"},"wordCount":622,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO14892&sd=2020-12-07","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/","name":"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO14892&sd=2020-12-07","datePublished":"2020-12-07T09:14:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO14892&sd=2020-12-07","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO14892&sd=2020-12-07"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncopeptides-will-host-a-webcast-on-wednesday-december-9th-at-1400-cet-to-provide-an-update-regarding-data-presented-at-the-ash-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=393966"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393966\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=393966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=393966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=393966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}